Broadwood Challenges Alcon Deal as STAAR Surgical Shareholder Vote Looms

Reuters12-17

Broadwood Challenges Alcon Deal as STAAR Surgical Shareholder Vote Looms

STAAR Surgical Company is facing heightened shareholder activism in the lead-up to its special meeting of stockholders scheduled for December 19, 2025. Broadwood Partners, L.P., which has increased its stake in STAAR to over 30% of outstanding shares, has taken an activist stance by threatening to pursue a proxy contest to remove three of STAAR’s six directors. This move could give Broadwood greater influence over the company without paying a control premium to other shareholders. Meanwhile, STAAR’s board has urged shareholders to vote in favor of the proposed merger with Alcon Inc., which offers $30.75 per share in cash, representing a 74% premium to STAAR’s 90-day volume-weighted average price as of August 4, 2025. The company’s leadership has emphasized the certainty and immediate value of the Alcon transaction amid ongoing shareholder activism.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STAAR Surgical Company published the original content used to generate this news brief on December 17, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2592116799?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-17 23:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2592116799","market":"us","top_or_hot":-1,"title":"Broadwood Challenges Alcon Deal as STAAR Surgical Shareholder Vote Looms","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Broadwood Challenges Alcon Deal as STAAR Surgical Shareholder Vote Looms\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/STAA\">STAAR Surgical Company</a> is facing heightened shareholder activism in the lead-up to its special meeting of stockholders scheduled for December 19, 2025. Broadwood Partners, L.P., which has increased its stake in STAAR to over 30% of outstanding shares, has taken an activist stance by threatening to pursue a proxy contest to remove three of STAAR’s six directors. This move could give Broadwood greater influence over the company without paying a control premium to other shareholders. Meanwhile, STAAR’s board has urged shareholders to vote in favor of the proposed merger with <a href=\"https://laohu8.com/S/ALC\">Alcon Inc</a>., which offers $30.75 per share in cash, representing a 74% premium to STAAR’s 90-day volume-weighted average price as of August 4, 2025. The company’s leadership has emphasized the certainty and immediate value of the Alcon transaction amid ongoing shareholder activism.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STAAR Surgical Company published the original content used to generate this news brief on December 17, 2025, and is solely responsible for the information contained therein.</span></i>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Broadwood Challenges Alcon Deal as STAAR Surgical Shareholder Vote Looms</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBroadwood Challenges Alcon Deal as STAAR Surgical Shareholder Vote Looms\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-17 23:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Broadwood Challenges Alcon Deal as STAAR Surgical Shareholder Vote Looms\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/STAA\">STAAR Surgical Company</a> is facing heightened shareholder activism in the lead-up to its special meeting of stockholders scheduled for December 19, 2025. Broadwood Partners, L.P., which has increased its stake in STAAR to over 30% of outstanding shares, has taken an activist stance by threatening to pursue a proxy contest to remove three of STAAR’s six directors. This move could give Broadwood greater influence over the company without paying a control premium to other shareholders. Meanwhile, STAAR’s board has urged shareholders to vote in favor of the proposed merger with <a href=\"https://laohu8.com/S/ALC\">Alcon Inc</a>., which offers $30.75 per share in cash, representing a 74% premium to STAAR’s 90-day volume-weighted average price as of August 4, 2025. The company’s leadership has emphasized the certainty and immediate value of the Alcon transaction amid ongoing shareholder activism.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STAAR Surgical Company published the original content used to generate this news brief on December 17, 2025, and is solely responsible for the information contained therein.</span></i>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL9n6DMK:1","article_id":"2592116799","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2592116799","pubTimestamp":1765987094,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"STAAR Surgical Company is facing heightened shareholder activism in the lead-up to its special meeting of stockholders scheduled for December 19, 2025. Broadwood Partners, L.P., which has increased its stake in STAAR to over 30% of outstanding shares, has taken an activist stance by threatening to pursue a proxy contest to remove three of STAAR’s six directors. This move could give Broadwood greater influence over the company without paying a control premium to other shareholders. Meanwhile, STAAR’s board has urged shareholders to vote in favor of the proposed merger with Alcon Inc., which offers $30.75 per share in cash, representing a 74% premium to STAAR’s 90-day volume-weighted average price as of August 4, 2025. The company’s leadership has emphasized the certainty and immediate value of the Alcon transaction amid ongoing shareholder activism.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4198":"医疗保健用品","BK4585":"ETF&股票定投概念","BK4548":"巴美列捷福持仓","STAA":"STAAR Surgical Company"},"translate_title":"随着STAAR Surgical股东投票临近，布罗德伍德挑战爱尔康交易","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"STAA":0.9},"content_text":"Broadwood Challenges Alcon Deal as STAAR Surgical Shareholder Vote Looms\n    \n\nSTAAR Surgical Company is facing heightened shareholder activism in the lead-up to its special meeting of stockholders scheduled for December 19, 2025. Broadwood Partners, L.P., which has increased its stake in STAAR to over 30% of outstanding shares, has taken an activist stance by threatening to pursue a proxy contest to remove three of STAAR’s six directors. This move could give Broadwood greater influence over the company without paying a control premium to other shareholders. Meanwhile, STAAR’s board has urged shareholders to vote in favor of the proposed merger with Alcon Inc., which offers $30.75 per share in cash, representing a 74% premium to STAAR’s 90-day volume-weighted average price as of August 4, 2025. The company’s leadership has emphasized the certainty and immediate value of the Alcon transaction amid ongoing shareholder activism.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STAAR Surgical Company published the original content used to generate this news brief on December 17, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding,event","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2592116799","isCrawlerRequest":true}